These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3010112)

  • 21. Need for caution in interpretation of Western Blot tests for HIV.
    Roy S; Portnoy J; Wainberg MA
    JAMA; 1987 Feb; 257(8):1047. PubMed ID: 3027425
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiological survey of HIV infection in the Veneto region of Italy.
    Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O
    Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disinfection and inactivation of HTLV-III/LAV.
    Ronalds CJ; Grint PC; Kangro HD
    J Infect Dis; 1986 May; 153(5):996-7. PubMed ID: 3009641
    [No Abstract]   [Full Text] [Related]  

  • 24. False-positive anti-HTLV-III assay results and HLA-DR4.
    Kenrick KG; Bolton W; Doran TJ
    Med J Aust; 1985 Jul; 143(2):88-9. PubMed ID: 2991712
    [No Abstract]   [Full Text] [Related]  

  • 25. HTLV-III antibody in Edinburgh drug addicts.
    Peutherer JF; Edmond E; Simmonds P; Dickson JD; Bath GE
    Lancet; 1985 Nov; 2(8464):1129-30. PubMed ID: 2865601
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of a new assay for antibodies to LAV/HTLV III.
    Maskill W; Healey D; Wootten A; Silvester C; Johnson S; O'Dwyer C; Jacklin R; Pringle R; Gust I; Harden P
    J Virol Methods; 1986 Jul; 13(4):273-8. PubMed ID: 3018016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIDS: the significance of anti-HTLV-III antibodies.
    Robinson PA; Brough J; Haddy L; Belshe RB; Khakoo R; Stevenson MM
    W V Med J; 1985 Sep; 81(9):194-7. PubMed ID: 2998098
    [No Abstract]   [Full Text] [Related]  

  • 28. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.
    Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G
    Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship and difference between HIV-1 and HIV-2 with regard to the most frequently used tests for the detection of anti-HIV-1-antibodies].
    van den Akker R
    Ned Tijdschr Geneeskd; 1988 Jan; 132(2):57-9. PubMed ID: 2829036
    [No Abstract]   [Full Text] [Related]  

  • 30. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody to lymphadenopathy-associated virus/human T lymphotropic virus type III in various groups of illicit drug abusers in New York City.
    Maayan S; Backenroth R; Rieber E; Jainchill N; Yaeger A; De Leon G; Getchell JP; Miller SN; Pollack CC; Wormser GP
    J Infect Dis; 1985 Oct; 152(4):843. PubMed ID: 2995507
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus related to but not identical with LAV/HTLV-III in Cameroon.
    Fleury HJ; Babin M; Bonnici JF; Bailly C; Chancerel B; Le Bras M
    Lancet; 1986 Apr; 1(8485):854. PubMed ID: 2870334
    [No Abstract]   [Full Text] [Related]  

  • 33. HTLV antibodies in Italian patients with multiple sclerosis.
    Varmier O; Melioli G; Lillo F; Schito G; Repetto C; Ravegnani M; Battaglia M
    Ital J Neurol Sci; 1987 Jun; Suppl 6():51-2. PubMed ID: 2820895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

  • 35. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
    Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
    Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV antibodies in intravenous drug abusers.
    Wodak A; Gold J
    Med J Aust; 1986 Sep; 145(6):298. PubMed ID: 3018463
    [No Abstract]   [Full Text] [Related]  

  • 38. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
    Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ELISA method for false positive reaction for the human immunodeficiency virus in a patient with alcoholic liver disease].
    Clotet B; Grifol M; Bedini J; Foz M
    Med Clin (Barc); 1987 Feb; 88(8):347. PubMed ID: 3031394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.